News

FDA approves J&J’s Stelara for psoriatic arthritis

BY Alaric DeArment

HORSHAM, Pa. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for psoriatic arthritis, the company said Monday.

Janssen Biotech, a subsidiary of J&J, announced the approval of Stelara (ustekinumab) alone or combined with the common generic drug methotrexate for treating active psoriatic arthritis in adults. According to the National Psoriasis Foundation, the autoimmune disease is estimated to affect more than 2 million people in the United States and is characterized by joint inflammation and psoriasis skin lesions.

"It is critical for dermatologists and rheumatologists to be able to offer new and novel treatment options to our adult patients living with psoriatic arthritis, a disease where additional biologic options are very much needed," Tufts Medical Center specialist Alice Gottlieb said. "Therapy that targets the cytokines interleukin-12 and interleukin-23, two naturally occurring proteins believed to play a role in the development of this debilitating immune-mediated inflammatory disease, could improve patient care."


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Ahold supervisory board member resigns

BY Alaric DeArment

ZAANDAM, Netherlands — Royal Ahold supervisory board member Tom de Swaan will resign at the end of this month, the company said Monday.

Netherlands-based Ahold, the parent company of Ahold USA and U.S. supermarket banners Stop & Shop, Giant Food of Landover, Md., and Giant Food Stores of Carlisle, Pa., as well as the online grocer Peapod, said de Swaan would resign effective Sept. 30.

De Swaan’s resignation is a result of his Sept. 11 appointment as chairman of Zurich Insurance Group. He was appointed to Ahold’s supervisory board in 2007 and served as chairman of the audit committee, a role that fellow board member Stephanie Shern will fill following his departure.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Ideavillage names new president and COO

BY Jason Owen

WAYNE, N.J. — On Friday, Ideavillage Products Corporation announced the promotion of Ron Boger to president and COO. Playing a pivotal role in developing Ideavillage as one of the leading As Seen On TV companies in the industry, Boger is credited with bringing such item successes to the company as Stompeez, Bright Light Pillows, Fushigi, Smooth Away, Slim Shots, and more.

“Ron holds a tenured and distinguished career in retail and distribution," said Andy Khubani, CEO and founder of Ideavillage. "He understands the ASOTV industry and my business inside out, and has worked alongside me in building and maintaining top-to-top relationships with retailers across the country. I’m proud to name him president.”

Prior to Ideavillage, Boger served as the as president and CEO of Major Connections, Inc., senior vice president of Telebrands and vice president of Non-Foods, HBC and Pharmacy of Eagle Foods.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES